← Back to Search

Smell training for Coronavirus (CAPS Trial)

N/A

Waitlist Available

Research Sponsored by Université de Montréal

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up week 14 and week 26

Awards & highlights

CAPS Trial Summary

This trial aims to find efficient treatments to help those with chemosensory losses due to Coronavirus disease (COVID-19). 75 participants will be recruited and randomly assigned to one of three groups: physical activity, smell training, or control. The groups will engage in their assigned activities for 12 weeks and be assessed at the beginning, end, and 12 weeks after the end of the intervention period.

Eligible Conditions

Coronavirus

CAPS Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ week 14 and week 26

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~week 14 and week 26

This trial's timeline: 3 weeks for screening, Varies for treatment, and week 14 and week 26 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Changes from Baseline in Brain Responses Following Smell Stimulations at Week 14

Changes from Baseline in Brain Responses Following Taste Stimulations at Week 14

Changes from Baseline in Food Preference on the Leeds Food Preference Questionnaire (LFPQ) at Week 14

+11 more

Secondary outcome measures

Change from Baseline in physical activity level on the International Physical Activity Questionnaire (IPAQ) at week 14

Change from Week 14 in physical activity level on the International Physical Activity Questionnaire (IPAQ) at week 26

CAPS Trial Design

3Treatment groups

Experimental Treatment

Active Control

Group I: Physical activity groupExperimental Treatment1 Intervention

Group II: Chemosensory training groupExperimental Treatment1 Intervention

Group III: Control groupActive Control1 Intervention

For 12 weeks, continue the participant's routine (no intervention). This is done remotely. Then, every two weeks, complete an online follow-up questionnaire (15 minutes each).

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Physical activity

2011

Completed Phase 2

~4740

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Université de MontréalLead Sponsor

213 Previous Clinical Trials

102,646 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

To what extent is the patient population involved in this trial?

"Correct. According to the clinicaltrials.gov website, this medical experiment is actively looking for participants. The trial was initially posted on October 25th 2021 and it has been updated as recently as November 9th 2021. Currently, 75 individuals need to be enrolled at 1 site."

Answered by AI

Are there still slots available to join the clinical trial?

"Correct. Clinicaltrials.gov indicates that this trial, first posted on October 25th 2021, is currently seeking participants. The experiment needs to recruit a total of 75 patients from one location."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Physical Activity and Smell Trainings to Help Individuals With Coronavirus Disease (COVID-19) Recover From Persistent Smell and Taste Impairments - A Pilot Study

Marie-Ève Mathieu 2021. "Physical Activity and Smell Trainings to Help Individuals With Coronavirus Disease (COVID-19) Recover From Persistent Smell and Taste Impairments - A Pilot Study". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05037110.

All > Coronavirus